Vaccine Development
Statistical approaches to vaccine evaluation reviewed
Published in Medical Letter on the CDC and FDA, July 10th, 2005
"Part 2 of this series investigates the statistical considerations of vaccine evaluation in an active-control trial. In particular, the strengths and weaknesses of the noninferiority methodology will be explored and contrasted for T-cell independent (does not elicit a memory response) and T-cell dependent (elicits a memory response) vaccines. At present, the noninferiority model is widely accepted as the primary tool for comparing the immunogenicity of a new or reformulated vaccine to an already existing licensed product," scientists writing in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Sexual Abuse
Method to discriminate abusive from nonabusive situations reported - Vaccine Efficacy
Racial and ethnic disparities exist in immunization coverage - Vaccine Efficacy
Statistical considerations for vaccine immunogenicity trials presented - Acinetobacter Baumannii Outbreaks
3rd-gen. cephalosporin therapy risk for VEB-1 ESBL A. baumannii outbreak - Acne
Trial of medical device for pimples information reported - Alzheimer Disease
Company files new drug application for compound to treat Alzheimer disease - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
